AIDS
- DUARTE MJ, Tien PC, Ma Y, French AL, et al
Higher plasma kynurenine-tryptophan ratio predicts incident hepatic fibrosis in
women with HIV.
AIDS. 2026 Oct 8. doi: 10.1097/QAD.0000000000004633.
- JOHN-STEWART G, Dyer J, Jiang W, Badia J, et al
Consent understanding and willingness to participate in research among
adolescents and young adults living with HIV.
AIDS. 2026 Oct 8. doi: 10.1097/QAD.0000000000004638.
- ABRESCIA N, Maddaloni A, Molinaro G, D'Abbraccio M, et al
Plasma-genital HIV-1 RNA discordance in women: early observations and biological
interpretation in the U=U era.
AIDS. 2026 Oct 8. doi: 10.1097/QAD.0000000000004634.
- BERENGUER J, Ryan P, Lutz T, Martin-Carbonero L, et al
Adherence to European AIDS clinical society hepatitis B management guidelines in
people with HIV: real-world evidence from Spain and Germany.
AIDS. 2026 Oct 8. doi: 10.1097/QAD.0000000000004635.
- WINSTON A, Gohil J, Keegan M, Alagaratnam J, et al
Tryptophan metabolomic profiling in persons with and without HIV.
AIDS. 2026 Oct 8. doi: 10.1097/QAD.0000000000004639.
- CRESTA M, Brun A, Merlet P, Hamet G, et al
Exercise testing and single-photon emission computed tomography myocardial
perfusion imaging to detect silent coronary heart disease in people with HIV.
AIDS. 2026 Oct 8. doi: 10.1097/QAD.0000000000004637.
- GOGINENI S, Nuwagaba G, Hooda M, Natukunda S, et al
Traditional healers in HIV differentiated service delivery.
AIDS. 2026 Oct 8. doi: 10.1097/QAD.0000000000004631.
- LI Y, Roan NR, Medvec T, Riddler S, et al
Female sex is associated with continuous decline in intact HIV-1 proviruses
during long-term antiretroviral therapy.
AIDS. 2026 Oct 8. doi: 10.1097/QAD.0000000000004632.
AIDS Res Hum Retroviruses
- EICHHOLZ K, Okoye AA, Varco-Merth BD, Gong J, et al
Safety of Autologous Infusion of CER T Cells in Nonhuman Primates.
AIDS Res Hum Retroviruses. 2026 Oct 7:8892229261490969.
- KA'E AC, Bouba Y, Ekwoge R, Ahmed A, et al
Willingness to Participate in HIV Cure Research Among Young People Living with
Perinatally Acquired HIV in the Centre Region of Cameroon: A Cross-Sectional
Survey.
AIDS Res Hum Retroviruses. 2026 Oct 7:8892229261495198.
Antimicrob Agents Chemother
- NUSSBAUM JC, Pham MM, Vargo R, Liu Y, et al
Open-label Phase 1 study to evaluate drug-drug interactions between ulonivirine
and islatravir in adults without HIV.
Antimicrob Agents Chemother. 2026 Oct 8:e0067626. doi: 10.1128/aac.00676.
BMJ
- COZZOLINO A
Turkey targets LGBTQI+ medical organisations, isolating arrested people with HIV.
BMJ. 2026;395:e101051.
Clin Infect Dis
- DE LAZZARI E, Chivite I, Merino-Penas MJ, Laguno M, et al
Interpreting Noninferiority in Risk-Stratified HIV Follow-up: Beyond a Single
Margin.
Clin Infect Dis. 2026 Oct 3:ciag625. doi: 10.1093.
- CHOUGLE AZ, Chougle SZ
Interpreting Post Hoc Noninferiority Analyses in Reduced-Frequency HIV Follow Up.
Clin Infect Dis. 2026 Oct 3:ciag624. doi: 10.1093.
- WOOD RC, Olson AM, Lochner KA, Dragovich RB, et al
Tongue Swab Mycobacterium tuberculosis Quantitative Polymerase Chain Reaction for
Community Screening of Asymptomatic Tuberculosis Versus Clinic-Based Triage of
Symptomatic Tuberculosis.
Clin Infect Dis. 2026 Oct 9:ciag443. doi: 10.1093.
Drugs
- FANUCCHI LC, Eaton E, Van Sickels N, Lofwall MR, et al
Infections and the Opioid Epidemic: Changing Epidemiology and Treatment Options.
Drugs. 2026 Oct 4. doi: 10.1007/s40265-026-02364.
HIV Med
- BLANKENBERGER J, Steffy TLF, Lee T, Makhesi T, et al
HIV viral suppression in children and adolescents who transitioned from
ritonavir-boosted lopinavir- to dolutegravir-based antiretroviral therapy in
Lesotho.
HIV Med. 2026 Oct 5. doi: 10.1111/hiv.70316.
- SMITH K, Locke M, Andersson E, Broddesson S, et al
Beyond CD4 counts: Multi-biomarker assessment of estimated time since HIV-1
infection and risk factors for late diagnosis.
HIV Med. 2026 Oct 6. doi: 10.1111/hiv.70314.
- KITONSA J, Komata R, Ssembajjwe W, Grint D, et al
A systematic review of evidence on weight change following initiation of
long-acting cabotegravir for the prevention or treatment of HIV.
HIV Med. 2026 Oct 8. doi: 10.1111/hiv.70319.
J Acquir Immune Defic Syndr
- LECATES A, Schwinne M, Yang M, Assi M, et al
Comparing Structural Determinants, Psychosocial Factors, and Individual-Level
Risk Indicators for Women's HIV Prevention in the Urban South.
J Acquir Immune Defic Syndr. 2026 Oct 8. doi: 10.1097/QAI.0000000000003984.
- FAMA R, Sassoon SA, Muller-Oehring EM, Saranathan M, et al
Postural instability in individuals living with HIV infection: Relations with
thalamic nuclei volumes, peripheral neuropathy, age, and falls.
J Acquir Immune Defic Syndr. 2026 Oct 8. doi: 10.1097/QAI.0000000000003983.
- ZIMBA R, Kelvin EA, Kulkarni S, Carmona J, et al
Exploring provider preferences for HIV treatment support packages integrating
long-acting injectable antiretroviral therapy in New York Ryan White Part A
medical case management programs.
J Acquir Immune Defic Syndr. 2026 Oct 7. doi: 10.1097/QAI.0000000000003978.
- CAIN D, Adhemar C, Howe K, Amin L, et al
Correlates of confidence to utilize non-occupational Post-Exposure Prophylaxis
(PEP) if needed among sexual minority men in relationships.
J Acquir Immune Defic Syndr. 2026 Oct 5. doi: 10.1097/QAI.0000000000003979.
J Am Acad Dermatol
- SMALE NE, Nguyen K, Mandal S, Friedman S, et al
Kaposi Sarcoma Is No Longer Predominantly HIV-Associated: Findings from a
Single-Center Retrospective Review.
J Am Acad Dermatol. 2026 Oct 8:S0190-9622(26)03719.
J Clin Invest
- JAMIL R, Huibner S, Yang P, Nnamutete J, et al
Impact of sexual debut on urethral immunology and microbiome in adolescent males
from Rakai, Uganda.
J Clin Invest. 2026 Oct 6:e208629. doi: 10.1172/JCI208629.
J Infect Dis
- FREEMAN ML, Honerkamp-Smith G, Wells A, Clagett BM, et al
Plasma Proteome Signature of Immune Inhibition is Associated with Cytomegalovirus
in People with HIV-1.
J Infect Dis. 2026 Oct 7:jiag498. doi: 10.1093.
- MAROTTI M, Epling BP, Angelova A, Segrist E, et al
Evaluation of gut microbiota composition in elite controllers and
antiretroviral-treated people with HIV after aspirin versus atorvastatin
administration.
J Infect Dis. 2026 Oct 9:jiag508. doi: 10.1093.
J Virol
- ZHANG D, Han J, Liu C, Lu J, et al
A four-amino-acid deletion in gp41 enhances HIV-1 CRF01_AE Cluster 4
pathogenicity and fusion inhibitor resistance.
J Virol. 2026 Oct 5:e0115826. doi: 10.1128/jvi.01158.
- EYMARD ED, Yalcin D, Ngalamika O, Lidenge SJ, et al
Humoral response against Epstein-Barr virus follows a strain-specific and
HIV-driven pattern.
J Virol. 2026 Oct 7:e0104326. doi: 10.1128/jvi.01043.
JAMA
- ANDERER S
Population Living With HIV Projected to Age in Coming Years.
JAMA. 2026 Oct 9. doi: 10.1001/jama.2026.20016.
Lancet
- BEKKER LG, Neilan AM
Closing the gap on mortality for adolescents living with HIV.
Lancet. 2026;408:1402-1404.
Nature
- NOGRADY B
'When prevention disappears, infections rise': can the world still end AIDS?
Nature. 2026;658:S5-S7.
PLoS Comput Biol
- CELESTE CG, Sokolik CC, Gachunga W, Parker IK, et al
Machine learning and Voronoi-based decision boundaries for Bacterial vaginosis to
determine population- specific microbial interactions.
PLoS Comput Biol. 2026;22:e1014767.
- LIU W, Shi Y, Guo X, Lou C, et al
Repurposing ritonavir to induce proteasomal degradation of IE1 for inhibition of
human cytomegalovirus replication.
PLoS Comput Biol. 2026;22:e1014867.
PLoS One
- TUSUBIRA AK, Ssemata AS, Katahoire AR, May C, et al
Self-care practices of people living with HIV and hypertension or diabetes
comorbidities in low-and-middle income countries: A systematic review.
PLoS One. 2026;21:e0360076.
- AYANKU S, Hanu EK, Akuba L, Tetteh C, et al
Seroprevalence and trends of transfusion-transmissible infections among blood
donors in the Volta Region, Ghana: A four-year retrospective study.
PLoS One. 2026;21:e0349548.
- LI X, Jorgensen D, Liu H, Nie Q, et al
Global spread and evolutionary trajectories of HIV-1 CRF01_AE: Insights from
phylogenetic analysis.
PLoS One. 2026;21:e0360404.
- WILKINSON T, Fortuin S, Hesseling AC, Schaaf HS, et al
Health system and household costs of preventive treatment delivery for children
exposed to multidrug-resistant tuberculosis in South Africa.
PLoS One. 2026;21:e0336561.
- CHIRIMO R, Zhou DT, Mudzviti T, Ruredzo IM, et al
Burden and determinants of hyperglycaemia and dyslipidaemia in Zimbabwean adults
living with HIV on dolutegravir-based first-line antiretroviral therapy: A
cross-sectional study.
PLoS One. 2026;21:e0359196.
- LU X, Zelnick J, Zhao M, Cummings M, et al
Temporal proximity to counseling is associated with longitudinal bedaquiline and
antiretroviral therapy adherence in multidrug-resistant tuberculosis and HIV
treatment.
PLoS One. 2026;21:e0355696.
PLoS Pathog
- ZHANG Y, Wang P, Zhang J, Wang Y, et al
KSHV K15 genetic heterogeneity is associated with Kaposi sarcoma aggressiveness
through modulation of the host inflammatory microenvironment.
PLoS Pathog. 2026;22:e1014615.
Free Medical Abstracts
Privacy Policy
Sponsors
Share
© Amedeo 1997-2016